期刊文献+

重组pCMV-N-Tudor-SN点突变质粒的构建及表达 被引量:1

Construction and expression of recombinant p CMV-N-Tudor-SN.Mutants Flag plasmids
下载PDF
导出
摘要 目的:构建Tudor-SN蛋白的Serine426(S426)、Serine781(S781)、Threonine240(T240)和Threonine429(T429)的点突变质粒,并使该重组质粒能够在He La细胞中融合表达。方法:利用定点突变技术,对Tudor-SN蛋白进行S426A、S781A、T240A、T429A点突变,通过双酶切的方法获得Tudor-SN.Mutants片段,最后将其连入到p CMV-N-Flag载体中。在He La细胞中转染该质粒,利用Western blot技术检测质粒表达效率。结果:(1)重组质粒经双酶切鉴定,可以观察到载体与Tudor-SN.Mutants的条带。(2)转染突变质粒后可看出He La细胞中有Flag蛋白表达。结论:质粒构建成功,可以用于下一步科学研究使用。 Objective: To construct eukaryotic Flag expressing recombinant pCMV-N-Tudor-SN.Mutants-Flag. Methods:The Serine426 (S426), Serine781 (S781), Threonine240(T240)and Threonineg29(T429) of Tudor-SN were transformed into Alanine by site- directed mutagenesis technique. Then the Tudor-SN.Mutants were obtained by restricting double enzyme digestion, and then inserted into pCMV- N-Flag vector. The recombinant plasmids were transfected into HeLa and observed by Western blot. Results: ( 1 ) The vector and Tudor-SN. Mutants could be observed by restricting double enzyme digestion. (2) Flag was expressed by HeLa which was transfected with recombinant plasmid. Conclusion:The recombinant plasmids of pCMV-N-Tudor-SN.Mutants-Flag are constructed successfully, and may be useful for further study.
出处 《天津医科大学学报》 2016年第1期5-8,共4页 Journal of Tianjin Medical University
基金 国家杰出青年基金资助项目(31125012) 教育部"创新团队发展计划"(IRT13085) 国家自然科学基金资助项目(31170830 31370749 31571380) 天津市应用基础与前沿技术研究计划(青年基金项目)(15JCQNJC09900)
关键词 人类Tudor-SN蛋白 pCMV-N-Flag 重组质粒 融合蛋白 human Tudor-SN pCMV-N-Flag recombinant plasmid fusion protein
  • 相关文献

参考文献18

  • 1Tong X, Drapkin R, Yalamanchili R, et al. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE[J]. Mol Cell Biol,1995, 15(9):4735.
  • 2Callebaut I, Mornon J P. The human EBNA-2 coactivator p100: multidomain organization and relationship to the staphylococcal nuclease fold and to the Tudor protein involved in Drosophila melanogaster development[J]. Biochem J, 1997, 321 (Pt 1 ):125.
  • 3Su C, Zhang C, Tecle A, et al. Tudor staphylococcal nuclease (Tudor-SN), a novel regulator facilitating G1/S phase transition, acting as a co-activator of E2F-1 in cell cycle regulation[J]. J Biol Chem, 2015, 290( 11 ) : 7208.
  • 4Duan Z, Zhao X, Fu X, et al. Tudor-SN, a novel coactivator of peroxisome proliferator-activated receptor 3' protein, is essential for adipogenesis[J]. J Biol Chem, 2014, 289 ( 12 ):8364.
  • 5Gao X, Ge L, Shao J, et al. Tudor-SN interacts with and co-localizes with G3BP in stress granules under stress conditions[J]. FEBS Lett, 2010, 584( 16):3525.
  • 6Valineva T, Yang J, Palovuori R, et al. The transeriptional co- activator protein p100 reeruits histone aeetyltransferase aetivity to STAT6 and mediates interaetion between the CREB-binding protein and STAT6[J]. J Biol Chern, 2005, 280( 15 ):14989.
  • 7Leverson J D, Koskinen P J, Orrieo F C, et al. Pim-1 kinase and p100 cooperate to enhance c-Myb activity[J]. Mol Cell, 1998, 2(4 ) :417.
  • 8Gao X, Shi X, Fu X, et al. Human Tudor staphylococcal nuclease (Tudor-SN) protein modulates the kinetics of AGTR1 -3"UTR granule formation[J].FEBS Lett, 2014, 588( 13 ):2154.
  • 9Chiosea S, Jelezcova E, Chandran U, et al. Overexpression of dicer in precursor lesions of lung adenocarcinoma[J]. Cancer Res, 2007, 67(5):2345.
  • 10Brito C C, Fachel A A, Vettore A L, et al. Identification of protein- coding and intronicnoncoding RNAs down-regulated in clear cell renal carcinoma[J]. Mol Carcing, 2008, 47( 10):757.

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部